Introducing a new personalised approach to cancer treatment pathways, made possible by our partnership with Datar Cancer Genetics

23Strands Cancer

We have partnered with leading genomics provider, Datar Cancer Genomics, to provide clinicians with personalised insights into alternative treatment options concerning their cancer patients.


  • Deep and extensive tumour gene expression analysis can generate relevant data that reveals possible targets for precision drug therapy.

  • Comprehensive genetic profiling of tumour tissue

  • Evaluate the effectiveness of responses and reactions to chemotherapy drugs

  • Provide efficacy and resistance guidance for chemotherapy

  • Deliver a non-invasive biopsy diagnostic tool through blood samples as an alternative substitute to invasive tissue extraction.

Learn More